Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|1|3|241-253

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.1, Iss.3, 2001-11, pp. : 241-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New setback for angiogenesis inhibitors

By  

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Angiogenesis New Targets for the Development of Anticancer Chemotherapies

By  

Current Pharmaceutical Design, Vol. 6, Iss. 4, 2000-03 ,pp. : 417-439

Bentham Science Publishers

Access to resources Recommend Favorite

The Rationale and Future Potential of Angiogenesis Inhibitors in Neoplasia

By Gasparini G.  

Drugs, Vol. 58, Iss. 1, 1999-07 ,pp. : 17-38

Adis International

Access to resources Recommend Favorite

Angiogenesis in Cardiovascular Disease: Current Status and Therapeutic Potential

By Sellke F.W.   Simons M.  

Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. : 391-396

Adis International

Access to resources Recommend Favorite

Anti-integrins as a potential therapeutic target in angiogenesis

By Mousa S.A.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. : 1237-1248

Informa Healthcare

Access to resources Recommend Favorite